Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Novartis AG grew revenues 6.05% from 50.14bn to 53.17bn while net income improved 63.72% from 7.70bn to 12.61bn.
Gross margin70.14%
Net profit margin13.53%
Operating margin16.22%
Return on assets5.26%
Return on equity10.59%
Return on investment6.79%
More ▼

Cash flow in USDView more

In 2018, Novartis AG increased its cash reserves by 49.79%, or 4.41bn. The company earned 14.27bn from its operations for a Cash Flow Margin of 26.84%. In addition the company used 5.59bn on investing activities and also paid 4.24bn in financing cash flows.
Cash flow per share5.52
Price/Cash flow per share16.96
Book value per share22.22
Tangible book value per share-1.01
More ▼

Balance sheet in USDView more

Novartis AG has a Debt to Total Capital ratio of 37.01%, a higher figure than the previous year's 29.63%.
Current ratio0.9405
Quick ratio0.7381
Total debt/total equity0.5886
Total debt/total capital0.3701
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.31%
Div growth rate (5 year)0.99%
Payout ratio (TTM)102.51%
EPS growth(5 years)7.73
EPS (TTM) vs
TTM 1 year ago
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.